ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2007;84:1685-1693. doi:10.1016/j.athoracsur.2007.04.076
© 2007 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David C. Rice
Ara A. Vaporciyan
Garrett L. Walsh
Stephen G. Swisher
Wayne L. Hofstetter
Reza J. Mehran
Jack A. Roth
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rice, D. C.
Right arrow Articles by Smythe, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rice, D. C.
Right arrow Articles by Smythe, W. R.
Related Collections
Right arrow Pleura


Original Articles: General Thoracic

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma

David C. Rice, MB, BCha,*, Craig W. Stevens, MD, PhDd, Arlene M. Correa, PhDa, Ara A. Vaporciyan, MDa, Anne Tsao, MDb, Kenneth M. Forster, PhDd, Garrett L. Walsh, MDa, Stephen G. Swisher, MDa, Wayne L. Hofstetter, MDa, Reza J. Mehran, MD, MSa, Jack A. Roth, MDa, Zhongxing Liao, MDc, W. Roy Smythe, MDe

a Department of Thoracic and Cardiovascular Surgery, University of Texas, MD Anderson Cancer Center, Houston, Texas
b Department of Thoracic Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas
c Department of Radiation Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas
d Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida
e Department of Surgery, Scott and White Clinic, Temple, Texas

Accepted for publication April 23, 2007.

* Address correspondence to Dr Rice, Department of Thoracic and Cardiovascular Surgery, Box 445, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (Email: drice{at}mdanderson.org).

Presented at the Fifty-third Annual Meeting of the Southern Thoracic Surgical Association, Tucson, AZ, Nov 8–11, 2006.

Background: Malignant pleural mesothelioma is a locally aggressive tumor that is usually fatal. Extrapleural pneumonectomy (EPP) followed by hemithoracic irradiation has shown promise, but local failure remains a significant problem. To improve local control, we have used intensity-modulated radiation therapy (IMRT) as it allows better dose distribution to regions at risk of recurrence as well as reduced radiation to surrounding organs.

Methods: One hundred consecutive patients underwent EPP. At a median interval of 2.5 months from surgery, 63 patients received IMRT (median dose 45 Gy) with curative intent. Chemotherapy was not routinely administered.

Results: Tumors were right sided in 66 patients (66%) and nonepithelioid in 33 (33%). American Joint Committee on Cancer pathology stage was I in 6 patients (6%), II in 7 (7%), III in 72 (72%), and IV (T4) in 15 (15%). Fifty-four patients (54%) had ipsilateral nodal metastases. Perioperative mortality was 8%. Median overall survival (n = 100) was 10.2 months. For patients who received IMRT (n = 63), median overall and 3-year survival was 14.2 months and 20%. Of these, node-negative patients with epithelioid histology (n = 18) had median and 3-year survival of 28 months and 41%. Distant recurrences occurred in 33 of 61 evaluable patients (54%). Eight patients (13%) had local or regional recurrence, 5 of whom also recurred distally. Only 3 patients (5%) had recurrence within the irradiated field.

Conclusions: Intensity-modulated radiation therapy after EPP results in excellent local control for malignant pleural mesothelioma; however, distant metastases remain a significant problem and limit survival. This provides a strong rationale for combining aggressive local regimens with systemic therapy.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. C. Mineo, V. Ambrogi, E. Pompeo, A. Baldi, F. Stella, P. Aurea, and M. Marino
The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
Ann. Thorac. Surg., May 1, 2008; 85(5): 1740 - 1746.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.